Overview

Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI

Status:
Unknown status
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to objectively assess the change (improvement) in exercise capacity in patients undergoing routine percutaneous coronary intervention (PCI) for chronic total occlusion (CTO)
Details
Lead Sponsor:
Henry Ford Health System
Treatments:
Clopidogrel
Ticlopidine